Originally known for its role in the oncogenic fusion gene in anaplastic large cell lymphoma, ALK has been established as a treatment target in various cancers, including subgroups of non-small cell lung cancer and colorectal carcinoma [7–10]. Here, ALK is linked to non-small cell lung carcinoma.